Collplant Biotechnologies Ltd (CLGN) Stock Analysis
Verdict: AVOID
Imminent dilution risk from a ~7.6-month cash runway and continuous earnings misses overshadow proprietary rhCollagen platform potential.
Investment score: 22/100
Analysis as of
Is Collplant Biotechnologies Ltd stock worth reviewing? AI model thesis
The AI model recommends AVOID for CLGN due to acute dilution risk (~7.6 months cash runway), multi-year cash burn (-$9.42M in 2025), and a persistent streak of quarterly earnings misses.
7-factor investment score
- Valuation: 20/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Collplant Biotechnologies Ltd opportunities and risks
What speaks for CLGN
- Strategic partnerships with AbbVie and 3D Systems for bioprinting and aesthetics
What speaks against CLGN
- Acute dilution risk with cash runway estimated at only ~7.6 months
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CLGN | n/a | 11.6x | n/a | -319.3% | -3376.3% | -257.1% |
| PLUR | n/a | 12.1x | n/a | 44.6% | -2406.0% | -164.4% |
| QNRX | n/a | 0.0x | n/a | 0.0% | 0.0% | -111.1% |
| NRSN | n/a | 0.0x | n/a | 0.0% | 0.0% | -32.0% |
| EVGN | n/a | 3.4x | 0.2x | -14.2% | -696.3% | -270.5% |
| SLXN | n/a | 0.0x | 0.0x | 0.0% | 0.0% | -8726.7% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -164.4% |
Frequently asked questions about Collplant Biotechnologies Ltd (CLGN)
Is CLGN stock a good investment?
The cached TradeMates AI model rates Collplant Biotechnologies Ltd as AVOID with an investment score of 22/100. The AI model recommends AVOID for CLGN due to acute dilution risk (~7.6 months cash runway), multi-year cash burn (-$9.42M in 2025), and a persistent streak of quarterly earnings misses. This is algorithmic model output, not personal investment advice.
Is CLGN stock a buy?
The TradeMates model verdict for CLGN is AVOID with an investment score of 22/100. Treat this as a model signal to review, not a personal buy recommendation.